Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance.

TitleMesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance.
Publication TypeJournal Article
Year of Publication2014
AuthorsDavidowitz RA, Selfors LM, Iwanicki MP, Elias KM, Karst A, Piao H, Ince TA, Drage MG, Dering J, Konecny GE, Matulonis U, Mills GB, Slamon DJ, Drapkin R, Brugge JS
JournalJ Clin Invest
Volume124
Issue6
Pagination2611-25
Date Published2014 Jun
ISSN1558-8238
KeywordsEpithelial-Mesenchymal Transition, Epithelium, Female, Gene Knockdown Techniques, Homeodomain Proteins, Humans, Mesoderm, Neoplasm Invasiveness, Nuclear Proteins, Ovarian Neoplasms, Peritoneal Neoplasms, Protein Array Analysis, Snail Family Transcription Factors, Spheroids, Cellular, Transcription Factors, Transcriptome, Tumor Cells, Cultured, Twist-Related Protein 1, Zinc Finger E-box-Binding Homeobox 1
Abstract

Metastatic dissemination of ovarian tumors involves the invasion of tumor cell clusters into the mesothelial cell lining of peritoneal cavity organs; however, the tumor-specific factors that allow ovarian cancer cells to spread are unclear. We used an in vitro assay that models the initial step of ovarian cancer metastasis, clearance of the mesothelial cell layer, to examine the clearance ability of a large panel of both established and primary ovarian tumor cells. Comparison of the gene and protein expression profiles of clearance-competent and clearance-incompetent cells revealed that mesenchymal genes are enriched in tumor populations that display strong clearance activity, while epithelial genes are enriched in those with weak or undetectable activity. Overexpression of transcription factors SNAI1, TWIST1, and ZEB1, which regulate the epithelial-to-mesenchymal transition (EMT), promoted mesothelial clearance in cell lines with weak activity, while knockdown of the EMT-regulatory transcription factors TWIST1 and ZEB1 attenuated mesothelial clearance in ovarian cancer cell lines with strong activity. These findings provide important insights into the mechanisms associated with metastatic progression of ovarian cancer and suggest that inhibiting pathways that drive mesenchymal programs may suppress tumor cell invasion of peritoneal tissues.

DOI10.1172/JCI69815
Alternate JournalJ Clin Invest
PubMed ID24762435
Grant ListCA016672 / CA / NCI NIH HHS / United States
Related Faculty: 
Tan Ince, M.D., Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700